SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-24-000175
Filing Date
2024-05-10
Accepted
2024-05-10 15:49:28
Documents
13
Period of Report
2024-05-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K rgbp051024form8k.htm   iXBRL 8-K 22784
  Complete submission text file 0001607062-24-000175.txt   193177

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rgbp-20240510.xsd EX-101.SCH 3254
3 XBRL LABEL FILE rgbp-20240510_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rgbp-20240510_pre.xml EX-101.PRE 22377
16 EXTRACTED XBRL INSTANCE DOCUMENT rgbp051024form8k_htm.xml XML 3671
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 24934552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)